Healty adult (subjects who is Impaired Glucose Tolerance and/or who is Impaired fasting glycaemia)
Conditions
Interventions
beverage containing resistant maltodextrin, 1 per serving
beverage not containing resistant maltodextrin, 1 per serving
Sponsors
KSO Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)(Healthy) males and females aged 20 to 64 years old. (2)Subjects whose fasting blood glucose levels are from 110 mg/dL to 125 mg/dL or whose OGTT test (after 2hours) blood glucose levels are from 140mg/dL to 199mg/dL. (3)Not heavy alcoholic drinker. (Subjects who can stop drinking from 2 days before each measurement.) (4)Subjects who can make self-judgment and are voluntarily giving written informed consent.
Exclusion criteria
Exclusion criteria: (1)Subjects who use oral medication affecting blood glucose. (2)Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting blood glucose. (3)Subjects who have declared allergic reaction to ingredients contained in test diets. (4)Subjects who need medical treatment for diabetes. (5)Subjects who contract or are under treatment or are medical history for serious diseases (e.g.,liver disease, kidney disease, and/or heart disease), thyroid gland disease, adrenal gland disease, and/or metabolic disorder. (6)Subjects who have a chronic disease and use medicines continuously. (7)Subjects who have a history of digestive disease affecting digestion and absorption. (8)Subjects who are judged as unsuitable for the study based on the results of blood tests by the investigator. (9)Subjects who have donated over 200 mL of blood and/or blood components within the last one month prior to the current study or over 400 mL of blood and/or blood components within the last three months prior to the current study. (10)Subjects who are diagnosed as anemic and not suitable for frequent collection of blood. (11)Subjects who are under treatment for or have a history of drug addiction and/or alcoholism. (12)Subjects who are planning to participate in other clinical studies. (13)Subjects who are planning to become pregnant after informed consent for the current study or are pregnant or lactating. (14)Subjects who are judged as unsuitable for the study by the investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postprandial blood glucose level | — |
Secondary
| Measure | Time frame |
|---|---|
| postprandial blood insulin level | — |
Countries
Japan
Contacts
Public ContactKomori Yoshika
KSO Corporation Sales department
Outcome results
None listed